This HTML5 document contains 214 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q36716188
rdf:type
wikibase:Item
schema:description
articol științific 2011年论文 2011 nî lūn-bûn artigo científico naučni članak bài báo khoa học наукова стаття, опублікована у вересні 2011 мақолаи илмӣ 2011年論文 scientific article published on 29 September 2011 ২৯ সেপ্টেম্বর ২০১১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ article scientifique مقالة علمية نشرت في 29 سبتمبر 2011 2011年论文 tieteellinen artikkeli 2011년 논문 teaduslik artikkel artykuł naukowy vedecký článok บทความทางวิทยาศาสตร์ 2011年論文 2011年论文 artikel ilmiah scienca artikolo научни чланак 2011年論文 scientific article published on 29 September 2011 2011年论文 vědecký článek artikulong pang-agham научная статья wissenschaftlicher Artikel 2011年の論文 scientific article published on 29 September 2011 2011年论文 article científic artigo científico научни чланак επιστημονικό άρθρο videnskabelig artikel vitskapeleg artikkel articolo scientifico article scientific 2011年论文 artículo científico publicado en 2011 artigo científico מאמר מדעי vitenskapelig artikkel 2011年論文 artikull shkencor bilimsel makale wetenschappelijk artikel научна статия artículu científicu espublizáu en 2011 სამეცნიერო სტატია 2011年論文 tudományos cikk vetenskaplig artikel
p:P577
wds:Q36716188-F0CA00A5-6DE9-4645-AEDD-3AE241C02AAB
wdt:P577
2011-09-29T00:00:00Z
p:P2860
wds:Q36716188-67CDA2A8-4161-49B7-8894-AB9F88491CFE wds:Q36716188-6DFA2F4C-CFE9-4325-B6B1-7FFCDB798484 wds:Q36716188-5CCC5BD7-428E-485C-B746-C0707CBC502C wds:Q36716188-7B1F0E74-C9F1-44AA-9F72-A6A0B3E6B6AA wds:Q36716188-735ED01A-695E-4618-8669-F8D65308756F wds:Q36716188-7989F4D4-20EB-43A8-9FE0-E902C443D75B wds:Q36716188-7A7D3093-1CF3-4EA4-B448-7F46AE4E11EC wds:Q36716188-9F05D25C-DA7E-4AF1-94C6-7D8935736B66 wds:Q36716188-9F3B2801-7E10-4730-A6E5-93BCE2DF213B wds:Q36716188-91CB1EFB-EEF7-475E-90E4-C2544EC96C7D wds:Q36716188-932C6E98-09E5-4B40-BCEC-48C7065D262B wds:Q36716188-952565F0-4D80-4A86-9012-8397F0B379EA wds:Q36716188-B6BFF8A7-51C1-4B86-B4E7-F506BAB575AB wds:Q36716188-B873BB4A-CB17-4B6F-B306-0A823165EABE wds:Q36716188-BACD4E29-B824-406B-87C1-75D011A59528 wds:Q36716188-A968FC45-E949-48D3-8937-84B8E997FE34 wds:Q36716188-B0DEF35B-B9F3-4EB9-BB09-08C3F1309579 wds:Q36716188-B59AD401-7B08-442B-9BE0-619166C8D28A wds:Q36716188-0187721F-3E39-4FAF-BA7E-D0A3C14D84BD wds:Q36716188-058ABBFB-51D4-4DE8-BBEC-F7766C4026A5 wds:Q36716188-15A887E4-5A41-454D-8820-B53D5A30E756 wds:Q36716188-D530D86C-5386-48F8-ACEC-8B369A6C88F7 wds:Q36716188-D9FF132D-C89F-4F94-A0AA-9B0A1ED52F50 wds:Q36716188-DC2AA07F-6F4D-49DF-90E5-925FC293557E wds:Q36716188-0BAD484C-9F63-4C42-A04B-D00BD9044EB6 wds:Q36716188-BBB8C21E-79F9-4A44-B649-26C602A7F61F wds:Q36716188-C2D0AF7F-FDB5-449D-886D-C0CCC068D99F wds:Q36716188-0FD7B2AF-0A47-4548-B339-D20A3BB3FE4F wds:Q36716188-C8716F5E-96CC-473B-9F92-D9ADCEECB655 wds:Q36716188-EE0F673C-88C0-4A64-9CCC-7F8DB73F9734 wds:Q36716188-4DCA35C7-E822-46D7-978F-41E299B47862 wds:Q36716188-55A6C112-01D1-497B-8268-D22662B994D8 wds:Q36716188-F1EB5E8A-274E-46B3-8045-3F2318571C1A wds:Q36716188-2C95D5B9-1018-4340-A3C5-227697E2CB85 wds:Q36716188-DEAC043C-D72F-4251-A92E-B8468D98905A wds:Q36716188-35B196B0-82A7-4A4A-B46A-5FF6F59F0DC0 wds:Q36716188-E8671986-CCD6-4123-A6C1-E448E629A739 wds:Q36716188-E9B39A4B-0A9A-48AE-AA03-73A3B34D67AC wds:Q36716188-409FF583-2951-4200-8CEE-C004EE0C8469 wds:Q36716188-FBBB0E4A-EFA3-47E5-B852-40BFAE2E7803 wds:Q36716188-F4065D08-ED64-4163-BD35-1616E59D577C
wdt:P2860
wd:Q64379589 wd:Q45843978 wd:Q77463980 wd:Q38477864 wd:Q62200249 wd:Q43575662 wd:Q64377626 wd:Q44696134 wd:Q37401749 wd:Q35833491 wd:Q45054598 wd:Q43723998 wd:Q50586082 wd:Q33543028 wd:Q34349918 wd:Q57107514 wd:Q40478100 wd:Q41522175 wd:Q35125131 wd:Q64378254 wd:Q44135294 wd:Q64383128 wd:Q37293675 wd:Q51198003 wd:Q36090231 wd:Q64378563 wd:Q64381139 wd:Q64377968 wd:Q43063896 wd:Q69819498 wd:Q44329265 wd:Q38482641 wd:Q64383568 wd:Q54777698 wd:Q50573909 wd:Q64378986 wd:Q46648242 wd:Q44318635 wd:Q41116120 wd:Q44383245 wd:Q34165176
p:P2093
wds:Q36716188-263E348E-72EF-45AA-A572-3129B21C7EEF wds:Q36716188-F602A4F6-C766-4644-8C9D-BADC9DFEC5AD wds:Q36716188-FB33BF7B-7A7F-4B85-B03A-CBA01F831DBB wds:Q36716188-F5E4BBA0-03A9-4CDE-A8BA-E95FD9D7D5DB wds:Q36716188-FBA7AC08-A00E-4E38-B3D5-1D27085E4E4D wds:Q36716188-90D9E2E6-CDB6-4BCE-9B1B-774E63ECFEE1 wds:Q36716188-A3AE0CCE-EF1E-445D-B6CA-3571EE5DE59B wds:Q36716188-EC099913-DA91-4732-A20B-6E61F294E26C wds:Q36716188-BAF3355D-99E1-4F68-BB88-7057E2902D64 wds:Q36716188-F344ECDE-7AB7-4E67-8E6A-5CEA1C58B50F wds:Q36716188-5CED7689-BD6A-4E91-9EA2-78399EC5BA20 wds:Q36716188-5D33F47F-4BD2-4F45-BB97-B8E2ED2CB8FD wds:Q36716188-5BB3D15B-4D90-4B58-879F-D192D24B262C wds:Q36716188-72A30771-8FF5-4E7C-999E-13C65A37A741 wds:Q36716188-769366F1-6DF4-4BCF-A7A6-164CF96C8D7D wds:Q36716188-8E29B2A4-ADE8-4CA9-A21D-89624F777F5E wds:Q36716188-8126F900-8FE4-4D81-8712-2A3FDB2943D0
wdt:P2093
Judith A Guzman-Cottrill Genovefa Papanicolaou Fang Qiu Christine Johnston Wendy Painter Jane Sande SingSing Way Steven A Pergam Randall Lanier Herve Mommeja-Marin Joseph Rigdon Joanne Kurtzberg Michael L Graham Diana F Florescu Michael N Neely Deborah A Lewinsohn Maggie Anderson
rdfs:label
Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients
skos:prefLabel
Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients
schema:name
Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients
p:P50
wds:Q36716188-373273CA-4248-49B8-A518-D8B70599BC83
wdt:P50
wd:Q46164894
p:P1476
wds:Q36716188-7219C088-0AA7-4F3B-A12A-86B2268431E9
wdt:P1476
Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients
p:P304
wds:Q36716188-1761EE17-555F-460D-AC40-FA9AF97F0815
wdt:P304
731-738
p:P31
wds:Q36716188-81584416-2E48-4FC9-9181-CADA6F2CC74F
wdt:P31
wd:Q13442814
p:P921
wds:Q36716188-473BFFF4-4014-412C-8AA9-5CAFDCE35EBD
wdt:P921
wd:Q193447
p:P698
wds:Q36716188-59F3F58D-1B6A-41B4-8E4C-C7164A964B11
wdtn:P698
n12:21963623
wdt:P698
21963623
p:P1433
wds:Q36716188-AD81A133-A912-4E05-9BB0-6AFAFEA016CD
wdt:P1433
wd:Q15754328
p:P433
wds:Q36716188-C386E036-7556-4F5B-9B98-CC8634850889
p:P478
wds:Q36716188-13467F94-34F5-4E35-B86B-5490BA957F4E
wdt:P433
5
wdt:P478
18
p:P356
wds:Q36716188-23BE3701-03B3-4E14-900B-41A9E6D48436
wdtn:P356
n10:J.BBMT.2011.09.007
wdt:P356
10.1016/J.BBMT.2011.09.007
p:P8608
wds:Q36716188-A653C192-4C1F-4E97-B1F3-A63DF66AA363
wdt:P8608
release_ce5nnkqqfjeqbkiuk6lwczqvaq
p:P5875
wds:Q36716188-0CDB9A69-45AE-403C-87AD-2D0DA55C75EE
wdt:P5875
51685690
p:P932
wds:Q36716188-D94E6BE7-59FE-4FC0-885A-CDC83627ADF7
wdt:P932
3608125